Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2015-01-29
DOI
10.1155/2015/357485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells
- (2015) Kyungsoo Ha et al. Oncotarget
- Predictive Factors and Patterns of Recurrence in Patients with Triple Negative Breast Cancer
- (2014) Lauren Steward et al. ANNALS OF SURGICAL ONCOLOGY
- Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
- (2014) María D Cuenca-López et al. BMC CANCER
- Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
- (2014) Jasmeet Chadha Singh et al. BREAST CANCER RESEARCH
- Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
- (2014) Pierluigi Gasparini et al. PLoS One
- Folate Receptor α Associated With Triple-Negative Breast Cancer and Poor Prognosis
- (2013) Zhang Zhang et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations
- (2013) S. Bayraktar et al. CLINICAL & EXPERIMENTAL METASTASIS
- MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer
- (2013) Alan Siroy et al. HUMAN PATHOLOGY
- Association betweenBRCAMutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation
- (2013) Jae Myoung Noh et al. Journal of Breast Cancer
- Prevalence ofBRCA1andBRCA2Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China
- (2013) Jianghua Ou et al. Journal of Breast Cancer
- Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
- (2013) David Cameron et al. LANCET ONCOLOGY
- Expression of androgen receptors in triple negative breast carcinomas
- (2012) Ivana Mrklić et al. ACTA HISTOCHEMICA
- Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor–Expressing Triple-Negative Breast Carcinoma
- (2012) Lisa M. Sutton et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
- (2012) Kate M Peters et al. BMC CANCER
- Expression and clinical significance of androgen receptor in triple negative breast cancer
- (2012) Xiang Luo et al. Chinese Journal of Cancer
- Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
- (2011) S. Park et al. ANNALS OF ONCOLOGY
- Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women
- (2011) E. Comen et al. BREAST CANCER RESEARCH AND TREATMENT
- Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer
- (2011) Juan Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
- (2011) Sibylle Loibl et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
- (2011) R. Hu et al. CLINICAL CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women
- (2011) Eunjung Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer
- (2011) Byung Joo Chae et al. JOURNAL OF SURGICAL ONCOLOGY
- The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer
- (2011) Dabei Tang et al. MEDICAL ONCOLOGY
- Clinical implications for BRCA gene mutation in breast cancer
- (2011) Jin Xu et al. MOLECULAR BIOLOGY REPORTS
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-Negative Breast Cancer
- (2010) Ayca Gucalp et al. CANCER JOURNAL
- Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations
- (2010) Gunda Pristauz et al. HISTOPATHOLOGY
- Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers
- (2010) Donata Micello et al. VIRCHOWS ARCHIV
- Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma
- (2010) Ja Seung Koo et al. YONSEI MEDICAL JOURNAL
- Immunohistochemical expression of epidermal growth factor receptor in breast cancer
- (2010) Tadahiro Nozoe et al. Breast Cancer
- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
- (2009) B. Corkery et al. ANNALS OF ONCOLOGY
- Expression of androgen receptors in primary breast cancer
- (2009) S. Park et al. ANNALS OF ONCOLOGY
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma
- (2009) J.-S. Guillamo et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
- (2009) Leo A Niemeier et al. MODERN PATHOLOGY
- Clinical and Pathologic Differences Between BRCA1-, BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country
- (2009) Cheng-Har Yip et al. WORLD JOURNAL OF SURGERY
- BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer
- (2008) Weiqiu Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
- (2008) Yoshinari Ogawa et al. International Journal of Clinical Oncology
- Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer
- (2008) Deann P. Atchley et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now